Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedNov 28, 2018Westminister Irbesartan TabletsCGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product.Sciegen Pharmaceuticals Inc · D-0267-2019Class IITerminatedNov 28, 2018Antacid TabletsPresence of foreign substance: Product found to contain metal particles.L. Perrigo Company · D-0266-2019Class IITerminatedNov 28, 2018IRBESARTAN TabletsCGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodiethylamine (NDEA) in product.Golden State Medical Supply Inc. · D-0265-2019Class IITerminatedNov 28, 2018IRBESARTAN TabletsCGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodiethylamine (NDEA) in product.Golden State Medical Supply Inc. · D-0264-2019Class IITerminatedNov 28, 2018IRBESARTAN TabletsCGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodiethylamine (NDEA) in product.Golden State Medical Supply Inc. · D-0263-2019Class ITerminatedNov 21, 2018Euphoric Premium Male Performance Enhancer capsulesMarketed Without An Approved NDA/ANDA: product contains undeclared sildenafil, tadalafil, and oxytetracycline, FDA approved drug products making Euphoric an unapproved...Epic Products, LLC · D-0288-2019Class IIITerminatedNov 21, 2018AMITIZAFailed Impurities/Degradation Specifications:Elevated levels of a known impurity in the 20-month stability sample testing.Takeda Development Center Americas, Inc. · D-0286-2019Class IIITerminatedNov 21, 2018Megestrol Acetate Oral SuspensionFailed Stability Specifications: Out-of-Specification results obtained for particle size distribution during stability testing.Breckenridge Pharmaceutical, Inc. · D-0279-2019Class IITerminatedNov 21, 2018children's allergy reliefFailed Impurities/Degradation Specifications: unknown impurity higher than the specified limit was detected during routine stability testing.Taro Pharmaceuticals U.S.A., Inc. · D-0278-2019Class IITerminatedNov 21, 2018children's allergyFailed Impurities/Degradation Specifications: unknown impurity higher than the specified limit was detected during routine stability testing.Taro Pharmaceuticals U.S.A., Inc. · D-0277-2019Class IITerminatedNov 21, 2018Children's 24 Hour AllergyFailed Impurities/Degradation Specifications: unknown impurity higher than the specified limit was detected during routine stability testing.Taro Pharmaceuticals U.S.A., Inc. · D-0276-2019Class IIITerminatedNov 21, 2018Nitrofurantoin CapsulesCross Contamination with Other ProductsSandoz Inc · D-0262-2019Class IITerminatedNov 21, 2018Isosorbide Dinitrate TabletsCross Contamination with Other ProductsSandoz Inc · D-0261-2019Class IITerminatedNov 21, 2018Isosorbide Dinitrate TabletsCross Contamination with Other ProductsSandoz Inc · D-0260-2019Class IITerminatedNov 21, 2018Isosorbide Dinitrate TabletsCross Contamination with Other ProductsSandoz Inc · D-0259-2019Class IITerminatedNov 21, 2018Isosorbide Dinitrate TabletsCross Contamination with Other ProductsSandoz Inc · D-0258-2019Class IIITerminatedNov 21, 2018Nitrofurantoin CapsulesCross Contamination with Other ProductsSandoz Inc · D-0257-2019Class ITerminatedNov 21, 2018puriton EYE RELIEF DROPSNon-Sterility: Product manufactured under non-sterile production conditions.Kadesh International · D-0250-2019Class IIITerminatedNov 21, 2018ERBITUX CETUXIMAB InjectionLabeling: Missing label; potential for missing primary container label on the vial.Eli Lilly & Co · D-0248-2019Class IITerminatedNov 21, 2018Zero Xtreme Dietary SupplementMarketed Without an Approved NDA/ANDA: Undeclared SibutramineZero Xtreme USA · D-0246-2019Class IIITerminatedNov 21, 2018Metoprolol Tartrate InjectionFailed pH Specifications: High Out-of-Specification results for pH were obtained during stability testing.RemedyRepack Inc. · D-0245-2019Class IITerminatedNov 21, 2018Alprostadil Injection USP 500 micrograms/mL 1 mL single use vialFailed Impurities/Degradation Specifications; out-of-specification results for impurities obtained during routine stability testingTeva Pharmaceuticals USA · D-0244-2019Class IIITerminatedNov 21, 2018Tadalafil SR 12 mg Capsules packed in 8Labeling Not Elsewhere Classified: Misbranding.Right Value Drug Stores, Inc. · D-0243-2019Class IIITerminatedNov 21, 2018Tadalafil SR 7 mg Capsules packed in 8Labeling Not Elsewhere Classified: Misbranding.Right Value Drug Stores, Inc. · D-0242-2019Class IIITerminatedNov 21, 2018Progesterone SR 200 mg CapsulesLabeling Not Elsewhere Classified: Misbranding.Right Value Drug Stores, Inc. · D-0241-2019Class IIITerminatedNov 21, 2018Progesterone SR 100 mg CapsulesLabeling Not Elsewhere Classified: Misbranding.Right Value Drug Stores, Inc. · D-0240-2019Class IITerminatedNov 14, 2018Healthful Naturals Leg Cramp Support Oral SprayCGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.Silver Star Brands · D-0256-2019Class IITerminatedNov 14, 2018Healthful Naturals DizziFree Oral SprayCGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.Silver Star Brands · D-0255-2019Class ITerminatedNov 14, 2018Native Remedies EyeClear Pro Oral SprayMicrobial Contamination of Non-Sterile ProductSilver Star Brands · D-0254-2019Class ITerminatedNov 14, 2018Native Remedies VaricoGo Oral SprayMicrobial Contamination of Non-Sterile ProductsSilver Star Brands · D-0253-2019Class ITerminatedNov 14, 2018Native Remedies HypoSlim Oral SprayMicrobial Contamination of Non-Sterile ProductsSilver Star Brands · D-0252-2019Class ITerminatedNov 14, 2018Native Remedies VertiFree Oral SprayMicrobial Contamination of Non-Sterile ProductsSilver Star Brands · D-0251-2019Class IITerminatedNov 14, 2018SparkleFresh Fluoride ToothpasteMicrobial Contamination of Non-Sterile ProductMedline Industries Inc · D-0247-2019Class IITerminatedNov 14, 2018Testosterone 200 mg/Anastrozole 20 mg pelletLack of Assurance of SterilityQualgen, LLC · D-0238-2019Class IITerminatedNov 14, 2018Testosterone 87.5mg pelletLack of Assurance of SterilityQualgen, LLC · D-0237-2019Class IITerminatedNov 14, 2018Testosterone 50mg pelletLack of Assurance of SterilityQualgen, LLC · D-0236-2019Class IITerminatedNov 14, 2018Testosterone 37.5 mg pelletLack of Assurance of SterilityQualgen, LLC · D-0235-2019Class IITerminatedNov 14, 2018Testosterone 25 mg pelletLack of Assurance of SterilityQualgen, LLC · D-0234-2019Class IITerminatedNov 14, 2018Testosterone 200mg pelletLack of Assurance of SterilityQualgen, LLC · D-0233-2019Class IITerminatedNov 14, 2018Testosterone 12.5mg pelletLack of Assurance of SterilityQualgen, LLC · D-0232-2019